Growth Metrics

Neogenomics (NEO) Depreciation and Depletion (2016 - 2025)

Neogenomics' Depreciation and Depletion history spans 16 years, with the latest figure at $8.8 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 10.83% year-over-year to $8.8 million; the TTM value through Dec 2025 reached $36.1 million, down 7.75%, while the annual FY2025 figure was $36.1 million, 7.75% down from the prior year.
  • Depreciation and Depletion reached $8.8 million in Q4 2025 per NEO's latest filing, roughly flat from $8.8 million in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $9.9 million in Q1 2024 to a low of $6.7 million in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $8.9 million, with a median of $9.1 million recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: rose 25.67% in 2022, then decreased 10.83% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $8.4 million in 2021, then increased by 13.04% to $9.5 million in 2022, then rose by 1.06% to $9.6 million in 2023, then grew by 2.6% to $9.8 million in 2024, then fell by 10.83% to $8.8 million in 2025.
  • Per Business Quant, the three most recent readings for NEO's Depreciation and Depletion are $8.8 million (Q4 2025), $8.8 million (Q3 2025), and $9.1 million (Q2 2025).